Literature DB >> 20826642

Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar.

Dilek Satana1, Ahmet Yilmaz Coban, Meltem Uzun.   

Abstract

In this study, the susceptibilities of 35 multidrug-resistant (MDR) Mycobacterium tuberculosis clinical isolates to second-line drugs, including kanamycin (KM), rifabutin (RBU), ofloxacin (OFX), p-aminosalicylic acid (PAS), capreomycin (CAP), clofazimine (CFM), and ethionamide (ETH), were investigated on blood agar according to CLSI recommendations. Compared with the results of the Bactec 460 TB system, agreement was 100, 100, 97, 100, 100, 100, and 86% for KM, RBU, OFX, PAS, CAP, CFM, and ETH, respectively. Compared with the results of the proportion method, agreement was 100, 100, 97, 100, 97, 100, and 77% for KM, RBU, OFX, PAS, CAP, CFM, and ETH, respectively.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20826642      PMCID： PMC3020831          DOI： 10.1128/JCM.00688-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

Authors:  G E Pfyffer; D A Bonato; A Ebrahimzadeh; W Gross; J Hotaling; J Kornblum; A Laszlo; G Roberts; M Salfinger; F Wittwer; S Siddiqi
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  Isoniazid susceptibilities of Mycobacterium tuberculosis on blood agar.

Authors:  Cilem Yildiz; Mahmut Ulger; Gonul Aslan; Gurol Emekdas
Journal:  Saudi Med J       Date:  2007-06       Impact factor: 1.484

3.  Evaluation of blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line antituberculous drugs: results from two centers.

Authors:  A Y Coban; A Martin; M Uzun; K Bilgin; J C Palomino; B Durupinar
Journal:  J Chemother       Date:  2008-06       Impact factor: 1.714

4.  Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar.

Authors:  Ahmet Yilmaz Coban; Kemal Bilgin; Meltem Uzun; Nuriye Tasdelen Fisgin; Alper Akgunes; Cigdem Cekic Cihan; Asuman Birinci; Belma Durupinar
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.

Authors:  S-Y Grace Lin; Edward Desmond; Donald Bonato; Wendy Gross; Salman Siddiqi
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

6.  Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  S H Siddiqi; J P Libonati; G Middlebrook
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

7.  Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.

Authors:  A Y Coban; C C Cihan; K Bilgin; M Uzun; A Akgunes; E Cetinkaya; B Durupinar
Journal:  Int J Tuberc Lung Dis       Date:  2006-04       Impact factor: 2.373

8.  Rapid culture of Mycobacterium tuberculosis on blood agar in resource limited setting.

Authors:  Murli L Mathur; Jyoti Gaur; Ruchika Sharma; Aruna Solanki
Journal:  Dan Med Bull       Date:  2009-11

9.  Comparative study for determination of Mycobacterium tuberculosis susceptibility to first- and second-line antituberculosis drugs by the Etest using 7H11, blood, and chocolate agar.

Authors:  Ahmet Yilmaz Coban; Kemal Bilgin; Meltem Uzun; Alper Akgunes; Anne Yusof; Belma Durupinar
Journal:  J Clin Microbiol       Date:  2008-10-22       Impact factor: 5.948

10.  Cost-effectiveness of blood agar for isolation of mycobacteria.

Authors:  Michel Drancourt; Didier Raoult
Journal:  PLoS Negl Trop Dis       Date:  2007-11-28
View more
  4 in total

1.  Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.

Authors:  A H Diacon; P R Donald; A Pym; M Grobusch; R F Patientia; R Mahanyele; N Bantubani; R Narasimooloo; T De Marez; R van Heeswijk; N Lounis; P Meyvisch; K Andries; D F McNeeley
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

Review 2.  Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.

Authors:  M Gopal; N Padayatchi; J Z Metcalfe; M R O'Donnell
Journal:  Int J Tuberc Lung Dis       Date:  2013-03-25       Impact factor: 2.373

3.  Rapid direct testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin on nutrient and blood agar in resource-starved settings.

Authors:  Luqman Satti; Aamer Ikram; Ahmet Yilmaz Coban; Anandi Martin
Journal:  J Clin Microbiol       Date:  2012-02-22       Impact factor: 5.948

4.  Blood agar validation for susceptibility testing of isoniazid, rifampicin, ethambutol, and streptomycin to Mycobacterium tuberculosis isolates.

Authors:  Ahmet Yilmaz Coban
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.